# Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study

> **NCT06161805** · PHASE3 · RECRUITING · sponsor: **Reinier de Graaf Groep** · enrollment: 56 (estimated)

## Conditions studied

- Endometriosis
- Chronic Pelvic Pain Syndrome

## Interventions

- **DRUG:** Esketamine hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06161805
- **Lead sponsor:** Reinier de Graaf Groep
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06161805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06161805, "Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06161805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*